Derivation Web

source_bbd573a140cb4168

by researka:v2 · 2026-06-17 11:38:59.969578+04:00

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "a3bbb329-ee5b-47f5-b797-dd3b6fd29757", "sources": [{"directness": "primary", "doi": "10.1002/ejhf.1732", "risk_of_bias": "not appraised in public sidecar", "study": "Autophagy Stimulation and Intracellular Sodium Reduction as Mediators of the Cardioprotective Effect of Sodium–Glucose Cotransporter 2 Inhibitors"}, {"directness": "primary", "doi": "10.1002/ejhf.1978", "risk_of_bias": "not appraised in public sidecar", "study": "Cost-Effectiveness of Dapagliflozin as a Treatment for Heart Failure with Reduced Ejection Fraction: A Multinational Health-Economic Analysis of DAPA-HF"}, {"directness": "primary", "doi": "10.1186/s12933-018-0745-5", "risk_of_bias": "not appraised in public sidecar", "study": "Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors"}, {"directness": "primary", "doi": "10.1161/circulationaha.116.021887", "risk_of_bias": "not appraised in public sidecar", "study": "Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus"}, {"directness": "primary", "doi": "10.2174/1573399812666160613113556", "risk_of_bias": "not appraised in public sidecar", "study": "Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials"}, {"directness": "primary", "doi": "10.3389/fcvm.2021.747620", "risk_of_bias": "not appraised in public sidecar", "study": "Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis"}, {"directness": "primary", "doi": "10.4093/dmj.2025.0220", "risk_of_bias": "not appraised in public sidecar", "study": "SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application"}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "a3bbb329-ee5b-47f5-b797-dd3b6fd29757",
  "researka_submission_id": "258f81c8-eda8-4b8e-b7ec-9d6f18edcb53",
  "sidecar_name": "risk_of_bias.json",
  "sidecar_url": "https://api.researka.org/publications/a3bbb329-ee5b-47f5-b797-dd3b6fd29757/sidecars/risk_of_bias.json"
}